about
Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.Gene therapy used for tissue engineering applications.Haemophilia therapies.Enhancing transduction of the liver by adeno-associated viral vectors.Influence of phospholipid composition on cationic emulsions/DNA complexes: physicochemical properties, cytotoxicity, and transfection on Hep G2 cells.Implications of decoupling the intracellular and extracellular levels in multi-level models of virus growth.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Current status and prospects for gene therapy.
@ast
Current status and prospects for gene therapy.
@en
type
label
Current status and prospects for gene therapy.
@ast
Current status and prospects for gene therapy.
@en
prefLabel
Current status and prospects for gene therapy.
@ast
Current status and prospects for gene therapy.
@en
P2093
P2860
P1433
P1476
Current status and prospects for gene therapy.
@en
P2093
Benjamin R
Davidoff AM
Nathwani AC
Nienhuis AW
P2860
P356
10.1111/J.1423-0410.2004.00543.X
P577
2004-08-01T00:00:00Z